{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:12:05Z","timestamp":1790007125739,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s43441-025-00782-2","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T18:23:26Z","timestamp":1745087006000},"page":"693-706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Navigating the Evolving Eurasian Economic Union\u2019s Pharmaceutical Landscape: Streamlining Drug Registration for Market Access"],"prefix":"10.1007","volume":"59","author":[{"given":"C. P.","family":"Keerthana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"782_CR1","unstructured":"Eurasian Economic Union [Internet]. [cited 2024 Jul 2];Available from: http:\/\/www.eaeunion.org\/?lang=en#about-countries"},{"key":"782_CR2","unstructured":"Thompson J, Thr\u00e4nert O, Wenger A, Haas M, Perovi\u0107 J, Watanabe L. Key Developments in Global Affairs [Internet]. 2019. Available from: www.css.ethz.ch\/publications\/strategic-trends"},{"key":"782_CR3","unstructured":"EAEU. EEC surveys medicine manufacturers about barriers [Internet]. 2024 [cited 2024 Jul 17];Available from: https:\/\/eec.eaeunion.org\/en\/news\/eek-oprashivaet-proizvoditeley-lekarstv-po-povodu-barerov-\/"},{"key":"782_CR4","unstructured":"Pr\u00fcfungsarbeit W, Des Titels E. Overview of Regulatory Requirements for Marketing Authorisations of Pharmaceutical Products in Countries of Eurasian Economic Union."},{"key":"782_CR5","unstructured":"Eurasian Economic Union. Agreement on Common Principles and Rules of Circulation of Medicinal Products Within the Eurasian Economic Union [Internet]. 2014 [cited 2024 Jul 25]. Available from: https:\/\/docs.eaeunion.org\/docs\/en-us\/01213250\/itia_24122014_doc.pdf"},{"key":"782_CR6","unstructured":"Eurasian Economic Commission. Concept of Harmonization of Pharmacopoeia of EAEU. 2015."},{"key":"782_CR7","unstructured":"Eurasian Economic Commission. Pharmacopoeia of the Eurasian Economic Union [Internet]. 2020 [cited 2024 Nov 20]. Available from: https:\/\/eec.eaeunion.org\/upload\/medialibrary\/37c\/PHARMACOPOEIA-of-the-Eurasian-Economic-Union.pdf"},{"key":"782_CR8","unstructured":"Eurasian Economic Commission. Decision 79 - Good Clinical Practice. 2016."},{"key":"782_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.33320\/maced.pharm.bull.2022.68.03.041","volume":"68","author":"L Karanakov","year":"2022","unstructured":"Karanakov L, Zafirova Georgievska K, Zisovska Beleva A, Dimovska J, Neceva S. Regulatory opportunities investigations -requirements and procedures for medicines registration in the EAEU and opportunities. Macedonian Pharm Bull. 2022;68:91\u20132.","journal-title":"Macedonian Pharm Bull"},{"key":"782_CR10","unstructured":"EAEU. Possibility to register medical products according to national rules extended [Internet]. 2023 [cited 2024 Jul 17];Available from: https:\/\/eec.eaeunion.org\/en\/news\/prodlena-vozmozhnost-registratsii-meditsinskikh-izdeliy-po-natsionalnym-pravilam\/"},{"key":"782_CR11","unstructured":"Pawar N, Alias Abhishek Garg H. Market Authorization Process for Medicinal Products in Eurasian Economic Union Council [Internet]. 2023. Available from: https:\/\/jrtdd.com."},{"key":"782_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.33380\/2305-2066-2022-11-1-159-164","volume":"11","author":"AV Foteeva","year":"2022","unstructured":"Foteeva AV, Barshadskaya OS, Rostova NB. Mutual recognition procedure for the registration of medicines: new challenges or opportunities. Drug Dev Registration. 2022;11:159\u201364.","journal-title":"Drug Dev Registration"},{"key":"782_CR13","unstructured":"On the rules of marketing authorization and assessment of medicinal products for human use."},{"key":"782_CR14","unstructured":"Zakharochkina ER, Rayisyan MG, Bekhorashvili N, Garankina RY, Ryajemov VV, Simonyan M. Uniform Rules for Registering Medicinal Products in the Eurasian Economic Union [Internet]. Available from: http:\/\/www.eurasiancommission.org\/"},{"key":"782_CR15","unstructured":"Eurasian Economic Commission. Rules of Procedure of the Expert Committee for Medicinal Products. 2016."},{"key":"782_CR16","first-page":"405","volume":"2018","author":"OP Zhangirqyzy","year":"2018","unstructured":"Zhangirqyzy OP. Multi-factor competitiveness analysis of the chemical and pharmaceutical industry in Eueu member States. J Social Sci Res. 2018;2018:405\u201313.","journal-title":"J Social Sci Res"},{"key":"782_CR17","unstructured":"Statista. Pharmaceuticals - EAEU [Internet]. [cited 2024 Aug 21];Available from: https:\/\/www.statista.com\/outlook\/hmo\/pharmaceuticals\/eaeu"},{"key":"782_CR18","unstructured":"Chameleon Pharma Consulting Group. EAEU Pharma Market [Internet]. [cited 2024 Aug 21];Available from: https:\/\/www.chameleon-pharma.com\/eaeu-gmp-and-registration-updates-are-you-prepared-for-the-2024-deadline\/"},{"key":"782_CR19","unstructured":"EAEU. Main directions for developing regulation of medicines circulation in EAEU presented at REGLEC 2023 conference [Internet]. 2023 [cited 2024 Aug 22];Available from: https:\/\/eec.eaeunion.org\/en\/news\/osnovnye-napravleniya-razvitiya-regulirovaniya-obrashcheniya-lekarstv-v-eaes-predstavleny-na-konfere\/"},{"key":"782_CR20","unstructured":"Tataritsky EAEUV. The EEC acts have provided a stable platform for functioning of the EAEU common market of medicines [Internet]. 2024 [cited 2024 Aug 22];Available from: https:\/\/eec.eaeunion.org\/en\/news\/valentin-tataritskiy-akty-eek-obespechili-stabilnuyu-platformu-dlya-funktsionirovaniya-obshchego-ryn\/"},{"key":"782_CR21","unstructured":"Pharmaceuticals - Kyrgyzstan [Internet]. Statista [cited 2024 Aug 24];Available from: https:\/\/www.statista.com\/outlook\/hmo\/pharmaceuticals\/kyrgyzstan#:~:text=Looking%20ahead%2C%20the%20industry%20is,US%2470.53m%20by%202029"},{"key":"782_CR22","unstructured":"Pharmaceuticals - Armenia [Internet]. Statista [cited 2024 Aug 24];Available from: https:\/\/www.statista.com\/outlook\/hmo\/pharmaceuticals\/armenia#:~:text=The%20Pharmaceuticals%20market%20in%20Armenia,US%24142.70m%20in%202024"},{"key":"782_CR23","unstructured":"Pharmaceuticals - Belarus [Internet]. Statista [cited 2024 Aug 24];Available from: https:\/\/www.statista.com\/outlook\/hmo\/pharmaceuticals\/belarus#:~:text=The%20market%20has%20experienced%20significant,trillion%20U.S.%20dollars%20in%202022"},{"key":"782_CR24","unstructured":"Pharmaceuticals - Kazakhstan [Internet]. Statista [cited 2024 Aug 24];Available from: https:\/\/www.statista.com\/outlook\/hmo\/pharmaceuticals\/kazakhstan#:~:text=It%20is%20expected%20that%20the,US%24599.30m%20by%202029"},{"key":"782_CR25","unstructured":"Pharmaceuticals - Russia [Internet]. Statista [cited 2024 Aug 24];Available from: https:\/\/www.statista.com\/outlook\/hmo\/pharmaceuticals\/russia#:~:text=The%20Pharmaceuticals%20market%20in%20Russia,US%241.23bn%20in%202024"},{"key":"782_CR26","doi-asserted-by":"publisher","first-page":"01025","DOI":"10.1051\/shsconf\/202111401025","volume":"114","author":"E Frolova","year":"2021","unstructured":"Frolova E, Turgel I, Ishukov A, Abdurahmanova Z. Peculiarities of the EEU countries interaction in pharmaceutical value chains in pandemic period. SHS Web Conferences. 2021;114:01025.","journal-title":"SHS Web Conferences"},{"key":"782_CR27","doi-asserted-by":"publisher","first-page":"S838","DOI":"10.1134\/S1019331622150084","volume":"92","author":"EI Pivovar","year":"2022","unstructured":"Pivovar EI. The Eurasian economic commission: from its origins to the present. Her Russ Acad Sci. 2022;92:S838\u201351.","journal-title":"Her Russ Acad Sci"},{"key":"782_CR28","unstructured":"Statista. Hand santizer - EAEU [Internet]. [cited 2024 Aug 23];Available from: https:\/\/www.statista.com\/outlook\/hmo\/otc-pharmaceuticals\/hand-sanitizer\/eaeu"},{"key":"782_CR29","unstructured":"Statista. Online Pharmacy - EAEU [Internet]. [cited 2024 Aug 23];Available from: https:\/\/www.statista.com\/outlook\/dmo\/digital-health\/digital-treatment-care\/digital-care-management\/online-pharmacy\/eaeu"},{"key":"782_CR30","unstructured":"Statista. Pharmaceuticals - EAEU [Internet]. [cited 2024 Aug 22];Available from: https:\/\/www.statista.com\/outlook\/hmo\/pharmaceuticals\/eaeu"},{"key":"782_CR31","unstructured":"Statista. OTC Pharmaceuticals - EAEU [Internet]. [cited 2024 Aug 22];Available from: https:\/\/www.statista.com\/outlook\/hmo\/otc-pharmaceuticals\/eaeu"},{"key":"782_CR32","unstructured":"Countrywiseexports2023-24."},{"key":"782_CR33","unstructured":"Eurasian Economic Commission. Amendment to the Rules for Registration and Examination of Medicinal Products for Medical Use (Decision no. 114). 2023."},{"key":"782_CR34","unstructured":"Freyr, EAEU\u2019s Decisions on Electronic Submissions - A Comprehensive Report for Drug Applicants [Internet]. 2020 [cited 2024 Aug 26];Available from: https:\/\/www.freyrsolutions.com\/blog\/eaeus-decisions-on-electronic-submissions-a-comprehensive-report-for-drug-applicants#:~:text=Decision%2079%20%E2%80%93%20Decision%2079%20emphasizes,specific%20types%20of%20XML%20files%3A"},{"key":"782_CR35","unstructured":"Cratia. Registration of medicines [Internet]. 2023 [cited 2024 Aug 20];Available from: https:\/\/cratia.com\/en\/countries\/eurasian-economic-union\/registration-of-medicines\/"},{"key":"782_CR36","unstructured":"Integrated information system of the Eurasian Economic. Union (integrated system) [Internet]. Portal of general information resources and open data [cited 2024 Nov 17];Available from: https:\/\/portal.eaeunion.org\/en-us\/public\/tech-iis.aspx"},{"key":"782_CR37","unstructured":"Eurasian Economic Commission. Procedures for Establishing and Operating the Eurasian Economic Union Common Register of Authorised Medicinal Products and Pharmaceutical Information Databases. 2016."},{"key":"782_CR38","doi-asserted-by":"crossref","unstructured":"Chaplenko A, Gildeeva G, Vlassov V. The entry lag of innovative drugs in Russia, 2010\u20132019. Int J Environ Res Public Health 2021;18.","DOI":"10.3390\/ijerph18105052"},{"key":"782_CR39","doi-asserted-by":"crossref","unstructured":"Zaremba AG, Rychikhina EM. Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regul Res Med Evaluation. 2023;13:586\u2013600. Analysis of the provisions of national and EAEU legislation regulating pharmaceuticals before and after 1 January 2026.","DOI":"10.30895\/1991-2919-2023-13-4-586-600"},{"key":"782_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.56012\/odis4682","volume":"32","author":"E Radkova","year":"2023","unstructured":"Radkova E, Petrova I. Clinical trials in the Eurasian economic union. Med Writ. 2023;32:66\u20138.","journal-title":"Med Writ"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-025-00782-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-025-00782-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-025-00782-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T18:39:27Z","timestamp":1750444767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-025-00782-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["782"],"URL":"https:\/\/doi.org\/10.1007\/s43441-025-00782-2","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}